Karolinska Development’s portfolio company AnaCardio has been granted additional EU patent for drug candidate AC01
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has been granted patent for its drug candidate AC01 as an inotropic agent in the EU. AnaCardio ...
Medscape24d
Heart Failure: Best Inotrope, Best Vasodilator, Indications for Biopsy
Hutter, Jr., M.D., M.A.C.C. When patients present with possible HF, initial evaluation requires a complete history and physical exam, including asking about past drug and alcohol use as well as ...
Medscape1mon
Switching Between Beta Blockers in Heart Failure Patients: Rationale and Practical Considerations
Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring intravenous positive inotropic agents, vasodilators, or mechanical ...
Karolinska Development AB (publ): Karolinska Development's portfolio company AnaCardio has been granted additional EU patent for drug candidate AC01
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has been granted patent for its drug candidate AC01 as an inotropic ...